Hanshang Group, Dikang Pharmaceutical deal published by SAMR for simple case review
MLex Summary: The proposed acquisition by department-store operator Hanshang Group of Chengdu Dikang Pharmaceutical has been published for a simple case review by the Antimonopoly Bureau of China’s State Administration for...To view the full article, register now.
Already a subscriber? Click here to view full article